Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwMyeloma 2015

11 April 2015

iwMyeloma 2015

11 April 2015
New immune-based therapies for multiple myeloma 12:26
New immune-based therapies for multiple myeloma
Kenneth Anderson • 11 Apr 2015
Early treatment and novel therapeutic targets for multiple myeloma 10:48
Early treatment and novel therapeutic targets for multiple myeloma
Antonio Palumbo et al. • 11 Apr 2015
Novel HDAC6 inhibitor, ricolinostat, for the treatment of multiple myeloma 4:11
Novel HDAC6 inhibitor, ricolinostat, for the treatment of multiple myeloma
Noopur Raje • 11 Apr 2015
Novel immunotherapies for the treatment of multiple myeloma 2:15
Novel immunotherapies for the treatment of multiple myeloma
Paul Richardson • 11 Apr 2015
Clinical utility of flow cytometry in multiple myeloma 7:22
Clinical utility of flow cytometry in multiple myeloma
Bruno Paiva • 11 Apr 2015
Emerging monoclonal antibodies for the treatment of multiple myeloma 1:26
Emerging monoclonal antibodies for the treatment of multiple myeloma
Rafael Fonseca • 11 Apr 2015
Minimal residue disease (MRD) in multiple myeloma 3:36
Minimal residue disease (MRD) in multiple myeloma
Rafael Fonseca • 11 Apr 2015
Prospective targeted therapies for multiple myeloma 1:40
Prospective targeted therapies for multiple myeloma
Philippe Moreau • 11 Apr 2015
Considerations for the early treatment of multiple myeloma 3:20
Considerations for the early treatment of multiple myeloma
Philippe Moreau • 11 Apr 2015
Optimizing proteasome inhibitors for the treatment of multiple myeloma 5:15
Optimizing proteasome inhibitors for the treatment of multiple myeloma
Robert Orlowski • 11 Apr 2015
Immunotherapy for the treatment of multiple myeloma 3:10
Immunotherapy for the treatment of multiple myeloma
David Avigan • 11 Apr 2015
Advances in monoclonal antibody therapy for multiple myeloma 3:36
Advances in monoclonal antibody therapy for multiple myeloma
Joseph Mikhael • 11 Apr 2015
Advances in the treatment of high-risk multiple myeloma 6:20
Advances in the treatment of high-risk multiple myeloma
Michele Cavo • 11 Apr 2015
Novel kinase targets as emerging therapies for multiple myeloma 6:05
Novel kinase targets as emerging therapies for multiple myeloma
Faith Davies et al. • 11 Apr 2015
Utilizing new understanding in multiple myeloma biology to guide treatment 9:31
Utilizing new understanding in multiple myeloma biology to guide treatment
Keith Stewart • 11 Apr 2015
The clinical implications of progenitor cells in multiple myeloma 16:59
The clinical implications of progenitor cells in multiple myeloma
Gareth Morgan et al. • 11 Apr 2015
The content of VJHemOnc is intended for healthcare professionals